Investigational New Drugs,volume 23,issue 3  (06-2014)

Period of time: 2014年3期

Publisher: Springer Publishing Company

Founded in: 1983

Total resources: 32

ISSN: 0167-6997

Subject: R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Investigational New Drugs,volume 23,issue 3

Menu

A mutated p53 status did not prevent the induction of apoptosis by sulforaphane, a promising anti-cancer drug

By Fimognari Carmela,Sangiorgi Luca,Capponcelli Silvia,Nüsse Michael,Fontanesi Silvia,Berti Fausto,Soddu Silvia,Cantelli-Forti Giorgio,Hrelia Patrizia in (2005)

Investigational New Drugs,volume 23,issue 3 , Vol. 23, Iss. 3, 2005-06 , pp. 195-203

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors

By Liang Jian,Moore Richard,Moher Eric,Munroe John,Al-awar Rima,Hay David,Varie David,Zhang Tony,Aikins James,Martinelli Michael,Shih Chuan,Ray James,Gibson Lowell,Vasudevan Vasu,Polin Lisa,White Kathryn,Kushner Juiwanna,Simpson Chiab,Pugh Susan,Corbett Thomas in (2005)

Investigational New Drugs,volume 23,issue 3 , Vol. 23, Iss. 3, 2005-06 , pp. 213-224

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam

By Kesteren Charlotte,Zandvliet Anthe,Karlsson Mats,Mathôt Ron,Punt Cornelis,Armand Jean-Pierre,Raymond Eric,Huitema Alwin,Dittrich Christian,Dumez Herlinde,Roché Henri,Droz Jean-Pierre,Ravic Miroslav,Yule S.,Wanders Jantien,Beijnen Jos,Fumoleau Pierre,Schellens Jan in (2005)

Investigational New Drugs,volume 23,issue 3 , Vol. 23, Iss. 3, 2005-06 , pp. 225-234

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancy

By Lim Dean,Morgan Robert,Akman Steven,Margolin Kim,Carr Brian,Leong Lucille,Odujinrin Oluwole,Doroshow James in (2005)

Investigational New Drugs,volume 23,issue 3 , Vol. 23, Iss. 3, 2005-06 , pp. 235-239

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Multi-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma

By Millward Michael,Joshua Anthony,Kefford Rick,Aamdal Steinar,Thomson Damien,Hersey Peter,Toner Guy,Lynch Kevin in (2005)

Investigational New Drugs,volume 23,issue 3 , Vol. 23, Iss. 3, 2005-06 , pp. 253-256

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Phase II trial of dolastatin-10 in patients with advanced breast cancer

By Perez Edith,Hillman David,Fishkin Paul,Krook James,Tan Winston,Kuriakose Phillip,Alberts Steven,Dakhil Shaker in (2005)

Investigational New Drugs,volume 23,issue 3 , Vol. 23, Iss. 3, 2005-06 , pp. 257-261

Springer Publishing Company

Abstract Access to resources Recommend Favorite